The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124535222 12453522 2 F 201209 20160114 20160609 20160720 EXP US-DSJP-DSU-2015-120149 DAIICHI 53.07 YR M Y 113.38000 KG 20160718 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124535222 12453522 1 PS BENICAR HCT HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL 1 40-25MG, QD 21532 FILM-COATED TABLET
124535222 12453522 2 SS BENICAR HCT HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL 1 40-12.5 MG 21532 FILM-COATED TABLET
124535222 12453522 3 SS BENICAR HCT HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL 1 UNK 21532 FILM-COATED TABLET
124535222 12453522 4 SS BENICAR OLMESARTAN MEDOXOMIL 1 20 MG, QD 1260 MG U 0 20 MG TABLET QD
124535222 12453522 5 SS BENICAR OLMESARTAN MEDOXOMIL 1 10 MG, QD 1260 MG U 0 10 MG TABLET QD
124535222 12453522 6 SS BENICAR OLMESARTAN MEDOXOMIL 1 20 MG, BID 1260 MG U 0 20 MG TABLET BID
124535222 12453522 7 SS BENICAR OLMESARTAN MEDOXOMIL 1 40 MG, UNK 1260 MG U 0 40 MG TABLET
124535222 12453522 8 C OXYCODONE OXYCODONE 1 UNK 0
124535222 12453522 9 C METOPROLOL. METOPROLOL 1 25 MG, BID 0 25 MG BID
124535222 12453522 10 C METOPROLOL. METOPROLOL 1 50 MG, BID 0 50 MG BID
124535222 12453522 11 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 1 TABLET A DAY 0
124535222 12453522 12 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 25 MG, QD 0 25 MG QD
124535222 12453522 13 C SPIRONOLACTONE. SPIRONOLACTONE 1 12.5 MG, QD 0 12.5 MG QD
124535222 12453522 14 C PRAVASTATIN. PRAVASTATIN 1 1 TABLET, QHS 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124535222 12453522 1 Hypertension
124535222 12453522 4 Hypertension
124535222 12453522 8 Product used for unknown indication
124535222 12453522 9 Product used for unknown indication
124535222 12453522 11 Product used for unknown indication
124535222 12453522 13 Product used for unknown indication
124535222 12453522 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
124535222 12453522 HO
124535222 12453522 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124535222 12453522 Chest pain
124535222 12453522 Dizziness
124535222 12453522 Malabsorption
124535222 12453522 Proctalgia
124535222 12453522 Rectal haemorrhage
124535222 12453522 Renal failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124535222 12453522 1 2012 0
124535222 12453522 2 20140716 0
124535222 12453522 3 2011 0
124535222 12453522 4 20120709 20120911 0
124535222 12453522 5 20120911 20121031 0
124535222 12453522 6 20121031 0
124535222 12453522 7 20130129 0
124535222 12453522 8 2012 0
124535222 12453522 9 20120224 0
124535222 12453522 10 20120224 0
124535222 12453522 11 20120304 20120315 0
124535222 12453522 12 20120520 0
124535222 12453522 13 20120523 0
124535222 12453522 14 20121031 0